Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
ID: 344457Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/344457

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-025.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00) to support the development of new independent researchers focused on tobacco product regulation. This funding opportunity aims to facilitate the transition of outstanding postdoctoral researchers into independent faculty positions, emphasizing research that informs the FDA's regulatory priorities under the Family Smoking Prevention and Tobacco Control Act. The award consists of two phases: a mentored K99 phase lasting up to two years, followed by an independent R00 phase for an additional three years, with a total funding amount of $750,000 available for approximately five awards. Interested applicants must submit their proposals through Grants.gov by the close date of March 12, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-OD-22-025.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA), announces the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00). This funding opportunity aims to cultivate a new cohort of independent researchers focused on tobacco product regulation, emphasizing research that informs FDA regulations in compliance with the Family Smoking Prevention and Tobacco Control Act. The award consists of two phases: the mentored K99 phase, lasting up to two years, followed by the independent R00 phase for an additional three years. Candidates must have no more than four years of postdoctoral experience and should propose research that is relevant to FDA’s regulatory priorities, including tobacco product composition, toxicity, public health impacts, marketing influences, and addiction. Eligible applicants include higher education institutions and qualified individuals with relevant research doctorates. The expected total funding from the FDA is $750,000 for approximately five awards. Applicants must follow strict instructions for submission via Grants.gov, and the application must showcase a well-structured plan for career development and research. The application cycle includes specific due dates, with the first due date occurring on February 21, 2023, emphasizing the need for applicants to plan accordingly.
    Similar Opportunities
    Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00), aimed at fostering a new generation of independent researchers in the field of tobacco regulation. This grant program is designed to support postdoctoral researchers transitioning to independent faculty positions, with a focus on research that informs the regulation of tobacco products as mandated by the Family Smoking Prevention and Tobacco Control Act. The K99 phase provides up to two years of mentored research training, followed by the R00 phase, which offers up to three years of independent research support, targeting areas such as tobacco product composition, health effects, addiction, and the evaluation of FDA regulatory actions. Applications are due periodically, with the next deadlines on November 14, 2023, and March 12, 2025. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), under the Department of Health and Human Services, is offering the Mentored Research Scientist Career Development Award (K01) in Tobacco Regulatory Research. This grant aims to support researchers in conducting studies that inform the U.S. Food and Drug Administration's (FDA) regulations on tobacco products, as mandated by the Family Smoking Prevention and Tobacco Control Act. The program is designed to foster independent research in critical areas such as product composition, toxicity, addiction, and health effects related to tobacco use, emphasizing the importance of tobacco regulatory science. Awardees are expected to commit at least 75% of their professional effort to the project, with NIH providing up to $90,000 per year for salary and research development expenses. Interested applicants must submit their proposals by March 12, 2025, and can find more information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01) to support intensive career development in research related to tobacco regulations. This grant aims to provide funding for projects that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing, in alignment with the FDA's regulatory authority under the Family Smoking Prevention and Tobacco Control Act. Eligible applicants include various higher education institutions and nonprofit organizations, with awards providing up to $90,000 annually for salary and $60,000 for research-related expenses. Interested applicants must submit their proposals by March 12, 2025, and can find additional information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at facilitating the transition of postdoctoral researchers into independent faculty positions. This program provides up to five years of support through two phases: the K99 phase offers up to two years of mentored training and research, while the R00 phase provides up to three years of independent research funding, contingent upon satisfactory progress and appointment to a qualifying faculty position. The initiative emphasizes the development of a diverse pool of skilled scientists and requires applicants to propose a significant research plan, establish a solid mentorship framework, and demonstrate institutional commitment to their career development. Interested applicants must submit their proposals by May 7, 2027, and can find additional information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting postdoctoral researchers in their transition to independent faculty positions. This program is designed to provide up to five years of funding, divided into two phases: the K99 phase for mentored training and the R00 phase for independent research, specifically targeting individuals with no more than four years of postdoctoral experience. The initiative emphasizes the importance of cultivating a diverse and skilled workforce in biomedical and clinical research, encouraging applications from underrepresented groups. Interested applicants must submit their proposals by May 7, 2027, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows to independent faculty positions. This program is specifically designed for researchers with clinical or research doctoral degrees who require minimal additional mentored training and are proposing to lead independent clinical trials or studies. The award consists of two phases: the K99 phase provides up to $100,000 annually for two years of mentored research, followed by the R00 phase, which offers up to $249,000 per year for three years of independent research. Interested applicants must adhere to detailed submission guidelines and can find more information at the provided NIH link. The application deadline is October 14, 2026, and inquiries can be directed to grantsinfo@nih.gov.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering the K99/R00 Pathway to Independence Award aimed at supporting early-stage postdoctoral researchers transitioning to independent research positions. This funding opportunity is designed for postdoctoral fellows with research or clinical doctoral degrees, focusing on studies involving human participants that meet the NIH definitions of clinical trials and basic research, particularly in cancer control, prevention, and data sciences. The program consists of a two-phase structure: the K99 phase provides up to two years of mentored support, while the R00 phase offers up to three years of independent research funding, contingent on progress and securing a faculty position. Interested applicants must adhere to strict guidelines and institutional nominations, with key deadlines approaching in January 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-288.html.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows into independent faculty positions in cancer research. This grant program is designed for researchers with doctoral degrees who require minimal additional mentored training, providing up to two years of support during the K99 phase followed by up to three years of independent research funding in the R00 phase. The initiative underscores NIH's commitment to strengthening the workforce in cancer research, particularly in areas such as cancer control and prevention, while ensuring that applicants present a comprehensive career development plan and mentorship strategy. Applications will open on January 14, 2024, with potential awards beginning in February 2024; interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting exceptional postdoctoral researchers in their transition to independent faculty positions while conducting basic experimental studies involving human subjects. This program is designed to facilitate a timely shift from mentored postdoctoral roles to independent research careers, providing funding for up to five years, divided into a mentored K99 phase (up to two years) and an independent R00 phase (up to three years), contingent upon successful transition to tenure-track or equivalent positions. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities and Tribal Colleges, with key application deadlines starting May 10, 2024, and the final submission date set for May 7, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage for additional details.
    Tobacco Regulatory Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Tobacco Regulatory Science (R01 Clinical Trial Optional)" funding opportunity, aimed at supporting biomedical and behavioral research to inform the regulation of tobacco products and protect public health. This initiative seeks R01 research project grant applications that address key research priorities, including the composition and design of tobacco products, toxicity assessments, addiction studies, and the health effects of tobacco use. A total of up to six R01 grants, with a combined funding of $4 million for fiscal year 2024, will be awarded to eligible applicants, which include a diverse range of institutions and organizations. Interested parties should submit their applications by May 4, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-23-017.html for further details.